The assessment of accuracy and precision in a routine clinical chemistry laboratory is discussed. A figure and tables are presented which relate the chance of making incorrect clinical decisions to the precision of an analytical method.
The question of accuracy and precision in clinical chemistry is frequently discussed (see, for instance, Thompson and Jones, 1965; Mitchell, 1966) . It is a waste of time in routine practice to strive for a degree of accuracy or precision which is greater than that required by clinicians. The object of this communication is to enable the performance of a laboratory method to be judged quantitatively in relation to clinical needs.
'Accuracy' is the extent to which a method measures what it sets out to measure. Determinations by an accurate method will not show systematic error, i.e., they will not differ consistently and in the same direction from the result which should be obtained. 'Precision' is the reproducibility of a method. A precise method has a small random error, i.e., there is little variation in results when the sample is run repeatedly. A method may be fairly precise but inaccurate, e.g., the determination of blood 'sugar' by the method of Folin and Wu.
In practice, systematic error may result either from the use ofinaccurate methods or from technical faults, such as the deterioration of standards or mistakes made in preparing solutions of reagents. Inaccurate methods should be replaced if possible by accurate methods, but the systematic method errors can be allowed for when the normal clinical range for a particular determination is defined. Systematic errors caused by technical faults are detectable by means of control charts.
The present communication is concerned with the random error of laboratory methods. The performance of a method is assessed by calculating the chance that diagnostic mistakes may occur as a result of method error. These diagnostic mistakes are of ' two types ( Fig. 1) : first, method error may cause the analytical result from a normal sample to fall outside the normal range; secondly, it may cause the analytical result from an abnormal sample to fall within the normal range. The chance of making either of these mistakes depends (1) on the size of the method error compared with that of the normal clinical range and (2) on the difference between the values of the normal limits and the true analytical value of the sample. Mistakes are most likely to occur when the true sample value is close to (either within or outside) the limits. As the true sample value moves away from the limits, the chance ofmistakes decreases at a rate which depends on the precision of the method. The greater the precision, the more rapidly the chance of mistakes decreases on either side of the limits.
The standards of precision achieved, or aimed at, in a routine clinical laboratory are thus directly related to the proportion of clinical mistakes which would be expected to occur within areas of uncertainty, defined in terms of the normal ranges for particular con- (1945 a, b) . It has been found that in non-Gaussian populations the logarithms of the actual analytical values usually follow a Gaussian distribution (Wootton, King, and Smith, 1951; Wootton, 1964 (Fisher and Yates, 1963 ) the standard deviation, a2, may be obtained by dividing the 98% range by 4-653, the 95% range by 3-920, the 90% range by 3 290, and the 80% range by 2 563. In this way, the same value of a2 is obtained in whatever way the normal range has been defined.
In Fig. 2 , the percentage of (a) 'normal' specimens classified as 'abnormal', and (b) 'abnormal' specimens classified as 'normal' are plotted for different ratios of a1 to a2 and for different true values of the analytical result on a particular sample. The normal range is defined by 90% limits in Figure 2 . True sample values (,u,) are expressed as positive deviations from the mid-point of the normal range, ua2, and are measured in terms of a2. The quantity (2 1) which is used for this purpose is a a2 'normal equivalent deviate' (see Gaddum, 1945a) . The chances that method error will cause the analytical result from an abnormal specimen whose true value is above the upper limit of normal to fall below the lower limit of normal, or vice versa, are negligible even in the extreme conditions of 80% limits and a1 / a2 = 1. In a normal specimen, analytical mistakes may cause the observed result to fall either above the upper limit or below the lower limit of normal. Both these types of mistakes are included in the total percentage of mistakes. The chances that both types of mistakes may occur at different times in repeated determinations on one particular specimen increase as (i2 -) approaches zero, but are neglig- A brief statistical derivation and data for normal ranges based on 80%, 95%, and 98% limits are given in the Appendix.
The use of Bodansky (1963) has pointed out that laboratory precision is important in follow-up studies on chemical changes in individual patients, as well as in assessing the chances of diagnostic error. Greater precision may be demanded for follow-up studies than for a simple diagnostic test, because the range of variation within a single individual may be smaller than the normal clinical range for all subjects. The precision necessary for follow-up studies can be assessed by comparing the size of the method error with the size of the variations normally encountered in serial determinations on the same individual, taking into account diurnal rhythms and day-to-day changes. The measurement of normal variability has been fully discussed elsewhere in relation tochanges in thecount of circulating eosinophils (Acland and Gould, 1956 
